4Mon·

Loser Johnson & Johnson

$JNJ (+0.17%)

The ongoing lawsuits over allegedly carcinogenic talcum powder products have put Johnson under pressure.

A US federal judge has refused to resolve the matter via insolvency proceedings.

The financial risk at Johnson is high, new uncertainty in the strategic direction.

Johnson the new Bayer $BAYN (+0.51%) and 3M $MMM (-0.52%) ?


Bottomless pit, the share has been in a volatile downward trend since 2022. Once again, the upper boundary line was not broken.

attachment
4
14 Comments

profile image
It's not the first time they've been the center of attention I just watched a series The Tylenol Murders on Netflix was also made there
1
Deleted User
4Mon
Comment was deleted
profile image
@Memo0606
$CORT
P/E ratio falls to 12
1
profile image
@Memo0606
My friend, what is your plan for the new week?
Deleted User
4Mon
Comment was deleted
profile image
@Memo0606
When will the position at Prismian be filled?
1
Deleted User
4Mon
Comment was deleted
profile image
@Memo0606
https://getqu.in/V8ZekW/

What's going on at Johnson?
Maybe a reason to sell
1
profile image
@Memo0606
You actually have good companies in your portfolio.
But I still don't see why Mongo's share price should rise. Profit growth is declining
Deleted User
4Mon
Comment was deleted
profile image
@Memo0606
Prologis doesn't convince me either. Unless the dividend yield is important to you
View all 3 further answers
Join the conversation